Catalyst Wire Dossier Catalyst Wire Dossier

JYNARQUE

tolvaptan · Otsuka America Pharmaceutical, Inc.
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for JYNARQUE, covering 2018-04-23 to 2025-12-10. Get the full timeline:

Most recent: Clinical Trial Update: Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD

See pricing